# Corcept Therapeutics (CORT) operating margin: 5.9% in 2025

URL: https://funkfolio.com/stock/CORT/operating-margin

> Corcept Therapeutics (CORT) operating margin was 5.9% in fiscal 2025, down 14.4 points from fiscal 2024. Its median over 14 fiscal years is 21.3%.

---

## Corcept Therapeutics (CORT) operating margin

**Operating margin · fiscal 2025:** 5.9% year ended Dec 31, 2025

Corcept Therapeutics (CORT) had an operating margin of 5.9% in fiscal 2025 (the year ended December 31, 2025). That is 14.4 percentage points lower than the 20.3% of fiscal 2024. Figures as of 17 Nov 2026, 22:04 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Operating margin, fiscal 2025:** 5.9%
- **Change on fiscal 2024:** −14.4 pts
- **Highest on record:** 36.4% fiscal 2019
- **Lowest on record:** -69827.6% fiscal 2009
- **Fiscal years on record:** 15 2009–2025

Figures as of 17 Nov 2026, 22:04 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

### Corcept Therapeutics operating margin, in more detail

Across the 15 fiscal years on record (2009–2025), the highest was 36.4% in fiscal 2019 and the lowest -69827.6% in fiscal 2009. The fiscal 2025 figure is higher than in 36% of the 14 earlier fiscal years on record, whose median is 21.3%.

Gross margin was 98.3% in fiscal 2025. Net margin was 13.1% in fiscal 2025.

### Operating margin by fiscal year

- Operating margin
- Gross margin
- Net margin

### Corcept Therapeutics operating margin, year by year

Corcept Therapeutics (CORT) operating margin by fiscal year

| Fiscal year | Operating margin | Change | Year ended | Gross margin | Net margin |
| --- | --- | --- | --- | --- | --- |
| 2025 | 5.9% | 14.4 pts down | Dec 31, 2025 | 98.3% | 13.1% |
| 2024 | 20.3% | 2.0 pts down | Dec 31, 2024 | 98.4% | 20.9% |
| 2023 | 22.2% | 5.8 pts down | Dec 31, 2023 | 98.7% | 22.0% |
| 2022 | 28.0% | 6.0 pts down | Dec 31, 2022 | 98.7% | 25.2% |
| 2021 | 34.0% | 2.2 pts down | Dec 31, 2021 | — | 30.7% |
| 2020 | 36.2% | 0.2 pts down | Dec 31, 2020 | — | 30.0% |
| 2019 | 36.4% | 0.8 pts up | Dec 31, 2019 | — | 30.7% |
| 2018 | 35.6% | 2.4 pts up | Dec 31, 2018 | — | 30.0% |
| 2017 | 33.2% | 20.7 pts up | Dec 31, 2017 | — | 81.1% |
| 2016 | 12.5% | 19.4 pts up | Dec 31, 2016 | — | 10.0% |
| 2015 | -6.8% | 97.2 pts up | Dec 31, 2015 | — | -12.7% |
| 2014 | -104.0% | 296.6 pts up | Dec 31, 2014 | — | -118.2% |
| 2013 | -400.7% | 696.2 pts up | Dec 31, 2013 | — | -444.3% |
| 2012 | -1096.8% | — | Dec 31, 2012 | — | -1150.5% |
| 2009 | -69827.6% | — | Dec 31, 2009 | — | -69537.9% |

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

### How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

### Operating margin at health care companies of similar size

Operating margin of Corcept Therapeutics and comparable companies

| Company | Operating margin | Fiscal year |
| --- | --- | --- |
| [10x Genomics TXG](https://funkfolio.com/stock/TXG/operating-margin) | -17.2% | 2025 |
| [HealthEquity HQY](https://funkfolio.com/stock/HQY/operating-margin) | 24.9% | 2026 |
| Corcept Therapeutics CORT | 5.9% | 2025 |
| [Rhythm Pharmaceuticals RYTM](https://funkfolio.com/stock/RYTM/operating-margin) | -101.2% | 2025 |
| [Alkermes ALKS](https://funkfolio.com/stock/ALKS/operating-margin) | 17.2% | 2025 |
| [PACS Group PACS](https://funkfolio.com/stock/PACS/operating-margin) | 5.9% | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Corcept Therapeutics, figure by figure

- [Corcept Therapeutics market cap](https://funkfolio.com/stock/CORT/market-cap)
- [Corcept Therapeutics revenue](https://funkfolio.com/stock/CORT/revenue)
- [Corcept Therapeutics earnings](https://funkfolio.com/stock/CORT/earnings)
- [Corcept Therapeutics earnings per share (EPS)](https://funkfolio.com/stock/CORT/eps)
- [Corcept Therapeutics P/E ratio](https://funkfolio.com/stock/CORT/pe-ratio)
- [Corcept Therapeutics P/S ratio](https://funkfolio.com/stock/CORT/ps-ratio)
- [Corcept Therapeutics P/B ratio](https://funkfolio.com/stock/CORT/pb-ratio)
- [Corcept Therapeutics free cash flow](https://funkfolio.com/stock/CORT/free-cash-flow)
- [Corcept Therapeutics dividend](https://funkfolio.com/stock/CORT/dividend)
- [Corcept Therapeutics shares outstanding](https://funkfolio.com/stock/CORT/shares-outstanding)
- [Corcept Therapeutics total debt](https://funkfolio.com/stock/CORT/total-debt)
- [Corcept Therapeutics cash on hand](https://funkfolio.com/stock/CORT/cash)
- [Corcept Therapeutics total assets](https://funkfolio.com/stock/CORT/total-assets)
- [Corcept Therapeutics return on equity (ROE)](https://funkfolio.com/stock/CORT/roe)
- [Corcept Therapeutics return on invested capital (ROIC)](https://funkfolio.com/stock/CORT/roic)

[Corcept Therapeutics (CORT) overview: price, valuation and scorecard](https://funkfolio.com/stock/CORT) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Corcept Therapeutics operating margin: questions and answers

**What is Corcept Therapeutics's operating margin?**

Corcept Therapeutics (CORT) had an operating margin of 5.9% in fiscal 2025 (the year ended December 31, 2025). That is 14.4 percentage points lower than the 20.3% of fiscal 2024.

**Is Corcept Therapeutics's operating margin high or low compared with its own history?**

The fiscal 2025 figure is higher than in 36% of the 14 earlier fiscal years on record, whose median is 21.3%.

**What are the highest and lowest operating margin figures on record for Corcept Therapeutics?**

Across the 15 fiscal years on record (2009–2025), the highest was 36.4% in fiscal 2019 and the lowest -69827.6% in fiscal 2009.

**What are Corcept Therapeutics's gross and net margins?**

Gross margin was 98.3% in fiscal 2025. Net margin was 13.1% in fiscal 2025.

**How is Corcept Therapeutics's operating margin calculated?**

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

### Learn: operating margin

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Revenue vs earnings vs free cash flow: what each tells you](https://funkfolio.com/learn/stocks/revenue-earnings-free-cash-flow)

  Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Corcept Therapeutics (CORT) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/CORT/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.
